A conversation with the Boston office of the U.S. Department of Health and Human Services Office of the Inspector General (OIG), Office of Evaluation and Inspections. The OIG has for decades served as the foremost government watchdog of federal healthcare programs, overseeing Medicare, Medicaid, the Food and Drug Administration, the National Institutes of Health, and the Centers for Disease Control and Services. Among other topics, the Boston office’s recent work has focused on the labeling of dietary supplements and human subjects protections, including the informational risks associated with biospecimen research and other topics.

Watch the video to learn about the work of the OIG, its role in the Department of Health and Human Services, and some of its current and past projects, as presented by Joyce Greenleaf, MBA, Regional Inspector General, and Jessica Fargnoli, MPH, Program Analyst (biographical details below). Matthew Lawrence moderates.

Co-sponsored by the Petrie-Flom Center and Harvard Catalyst.

Joyce Greenleaf is the Regional Inspector General for the Department of Health and Human Services Office of the Inspector General (OIG), Office of Evaluation and Inspections, in Boston. In this position, she has overseen evaluations on a wide range of issues. Her expertise includes the oversight of hospital quality, human subjects protections in clinical trials, and dietary supplements.

Joyce began her career with the OIG in 1986. She has served in various leadership positions including team leader and Assistant Regional Inspector General. She is co-author of the chapter entitled “The Ebb and Flow of Federal Initiatives to Regulate Healthcare Professionals,” published in Regulation of the Healthcare Professions in 1997. Prior to coming to the OIG, Joyce held research positions on a grant funded by the Robert Wood Johnson Foundation. Joyce is a graduate of Clark University where she earned a BA in Sociology and an MBA.

Jessica Fargnoli is a Program Analyst at the Department of Health and Human Services Office of Inspector General (OIG), Office of Evaluations and Inspections, in Boston. Jessica began her career with the OIG in 2010 and has conducted work related to dietary supplements, sterile compounded drugs, and FDA oversight of prescription drugs and medical devices. Prior to coming to the OIG, Jessica worked as an epidemiologist for the Massachusetts Department of Public Health. She also attended Boston University where she earned a BA in Biology and an MPH in Epidemiology.